1.000000
0.000000
0.000000
0.000000
1.000000
0.000000
0.000000
0.000000
1.000000
0.00000
0.00000
0.00000
Montserret, R.
Bartenschlager, R.
Penin, F.
http://mmcif.pdb.org/dictionaries/ascii/mmcif_pdbx.dic
C3 H7 N O2
89.093
y
ALANINE
L-peptide linking
C6 H15 N4 O2 1
175.209
y
ARGININE
L-peptide linking
C4 H7 N O4
133.103
y
ASPARTIC ACID
L-peptide linking
C3 H7 N O2 S
121.158
y
CYSTEINE
L-peptide linking
C5 H10 N2 O3
146.144
y
GLUTAMINE
L-peptide linking
C5 H9 N O4
147.129
y
GLUTAMIC ACID
L-peptide linking
C2 H5 N O2
75.067
y
GLYCINE
peptide linking
C6 H10 N3 O2 1
156.162
y
HISTIDINE
L-peptide linking
C6 H13 N O2
131.173
y
ISOLEUCINE
L-peptide linking
C6 H13 N O2
131.173
y
LEUCINE
L-peptide linking
C6 H15 N2 O2 1
147.195
y
LYSINE
L-peptide linking
C5 H11 N O2 S
149.211
y
METHIONINE
L-peptide linking
C9 H11 N O2
165.189
y
PHENYLALANINE
L-peptide linking
C5 H9 N O2
115.130
y
PROLINE
L-peptide linking
C4 H9 N O3
119.119
y
THREONINE
L-peptide linking
C5 H11 N O2
117.146
y
VALINE
L-peptide linking
US
Plos Pathog.
1553-7366
6
e1001233
e1001233
10.1371/journal.ppat.1001233
21187906
Structural and functional studies of nonstructural protein 2 of the hepatitis C virus reveal its key role as organizer of virion assembly.
2010
4275.298
Protease NS2-3
UNP residues 869-908
1
man
polymer
no
no
GRDAVILLTCAIHPELIFTITKILLAILGPLMVLQAGITK
GRDAVILLTCAIHPELIFTITKILLAILGPLMVLQAGITK
A
polypeptide(L)
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
HCV
sample
11103
Hepatitis C virus
Solution structure of Hepatitis C Virus NS2 protein segment 60-99
repository
Initial release
Version format compliance
1
0
2011-03-02
1
1
2011-07-13
BMRB
Y
RCSB
2010-04-22
REL
REL
structures with the least restraint violations
50
41
2D 1H-1H NOESY
2D 1H-1H TOCSY
2D 1H-13C HSQC
0.4
mM
50
%
[U-2H]
50
%
0.2
uM
0
6.0
ambient
298
K
torsion angle dynamics
1
closest to the average
0.4 mM NS2[60-99], 50 % v/v [U-2H] TFE, 50 % v/v H2O, 0.2 uM DSS, trifluoroethanol/water
trifluoroethanol/water
Bruker Biospin
collection
TOPSPIN
Goddard
data analysis
SPARKY
Schwieters, Kuszewski, Tjandra and Clore
structure solution
X-PLOR_NIH
2.24
Schwieters, Kuszewski, Tjandra and Clore
refinement
X-PLOR_NIH
2.24
500
Bruker
Avance
Bruker Avance
GLY
1
n
1
GLY
1
A
ARG
2
n
2
ARG
2
A
ASP
3
n
3
ASP
3
A
ALA
4
n
4
ALA
4
A
VAL
5
n
5
VAL
5
A
ILE
6
n
6
ILE
6
A
LEU
7
n
7
LEU
7
A
LEU
8
n
8
LEU
8
A
THR
9
n
9
THR
9
A
CYS
10
n
10
CYS
10
A
ALA
11
n
11
ALA
11
A
ILE
12
n
12
ILE
12
A
HIS
13
n
13
HIS
13
A
PRO
14
n
14
PRO
14
A
GLU
15
n
15
GLU
15
A
LEU
16
n
16
LEU
16
A
ILE
17
n
17
ILE
17
A
PHE
18
n
18
PHE
18
A
THR
19
n
19
THR
19
A
ILE
20
n
20
ILE
20
A
THR
21
n
21
THR
21
A
LYS
22
n
22
LYS
22
A
ILE
23
n
23
ILE
23
A
LEU
24
n
24
LEU
24
A
LEU
25
n
25
LEU
25
A
ALA
26
n
26
ALA
26
A
ILE
27
n
27
ILE
27
A
LEU
28
n
28
LEU
28
A
GLY
29
n
29
GLY
29
A
PRO
30
n
30
PRO
30
A
LEU
31
n
31
LEU
31
A
MET
32
n
32
MET
32
A
VAL
33
n
33
VAL
33
A
LEU
34
n
34
LEU
34
A
GLN
35
n
35
GLN
35
A
ALA
36
n
36
ALA
36
A
GLY
37
n
37
GLY
37
A
ILE
38
n
38
ILE
38
A
THR
39
n
39
THR
39
A
LYS
40
n
40
LYS
40
A
author_defined_assembly
1
monomeric
1.0000000000
0.0000000000
0.0000000000
0.0000000000
1.0000000000
0.0000000000
0.0000000000
0.0000000000
1.0000000000
1_555
x,y,z
identity operation
0.0000000000
0.0000000000
0.0000000000
1
A
ARG
2
0.254
SIDE CHAIN
2
A
ARG
2
0.311
SIDE CHAIN
3
A
ARG
2
0.317
SIDE CHAIN
4
A
ARG
2
0.314
SIDE CHAIN
5
A
ARG
2
0.291
SIDE CHAIN
6
A
ARG
2
0.317
SIDE CHAIN
7
A
ARG
2
0.299
SIDE CHAIN
8
A
ARG
2
0.258
SIDE CHAIN
9
A
ARG
2
0.317
SIDE CHAIN
10
A
ARG
2
0.301
SIDE CHAIN
11
A
ARG
2
0.317
SIDE CHAIN
12
A
ARG
2
0.314
SIDE CHAIN
13
A
ARG
2
0.305
SIDE CHAIN
14
A
ARG
2
0.307
SIDE CHAIN
15
A
ARG
2
0.315
SIDE CHAIN
16
A
ARG
2
0.316
SIDE CHAIN
17
A
ARG
2
0.314
SIDE CHAIN
18
A
ARG
2
0.317
SIDE CHAIN
19
A
ARG
2
0.317
SIDE CHAIN
20
A
ARG
2
0.315
SIDE CHAIN
21
A
ARG
2
0.315
SIDE CHAIN
22
A
ARG
2
0.296
SIDE CHAIN
23
A
ARG
2
0.294
SIDE CHAIN
24
A
ARG
2
0.313
SIDE CHAIN
25
A
ARG
2
0.317
SIDE CHAIN
26
A
ARG
2
0.262
SIDE CHAIN
27
A
ARG
2
0.312
SIDE CHAIN
28
A
ARG
2
0.312
SIDE CHAIN
29
A
ARG
2
0.304
SIDE CHAIN
30
A
ARG
2
0.318
SIDE CHAIN
31
A
ARG
2
0.315
SIDE CHAIN
32
A
ARG
2
0.312
SIDE CHAIN
33
A
ARG
2
0.318
SIDE CHAIN
34
A
ARG
2
0.317
SIDE CHAIN
35
A
ARG
2
0.316
SIDE CHAIN
36
A
ARG
2
0.312
SIDE CHAIN
37
A
ARG
2
0.308
SIDE CHAIN
38
A
ARG
2
0.311
SIDE CHAIN
39
A
ARG
2
0.318
SIDE CHAIN
40
A
ARG
2
0.295
SIDE CHAIN
41
A
ARG
2
0.315
SIDE CHAIN
1
A
ARG
2
-110.48
-169.17
1
A
ALA
4
-172.62
-50.13
2
A
ILE
27
-114.42
56.19
2
A
LEU
28
-100.17
-62.60
3
A
ALA
4
-173.62
-53.84
3
A
ALA
11
-100.05
43.74
3
A
GLN
35
-147.46
26.69
4
A
ALA
4
-176.71
-50.09
4
A
HIS
13
56.19
75.18
4
A
PRO
14
-74.53
-169.62
4
A
LEU
16
-174.51
-58.62
5
A
THR
39
-150.45
59.99
6
A
ARG
2
-108.30
42.94
6
A
ALA
11
-99.23
44.86
6
A
HIS
13
-158.59
66.24
6
A
ALA
36
-100.46
-64.05
6
A
THR
39
-112.46
50.47
7
A
ARG
2
-109.74
-161.55
7
A
ALA
4
-171.32
-57.45
7
A
THR
39
-145.75
44.66
8
A
PRO
14
-64.40
-167.04
8
A
LEU
16
-171.64
-53.78
9
A
ALA
11
-117.19
58.50
9
A
ILE
27
-125.52
-53.06
9
A
ALA
36
-103.85
70.69
9
A
THR
39
-153.03
72.10
10
A
LEU
16
-132.41
-50.08
10
A
THR
39
-161.44
42.12
11
A
LEU
16
-165.45
-55.70
11
A
ILE
27
-130.38
-57.32
12
A
HIS
13
66.36
94.01
12
A
ILE
27
-96.87
-69.18
12
A
THR
39
-154.37
53.66
13
A
PRO
30
-86.63
40.65
13
A
THR
39
-105.73
47.63
14
A
LEU
28
-118.77
-72.91
14
A
GLN
35
-149.52
27.09
14
A
THR
39
-157.23
32.06
15
A
LEU
16
-169.65
-55.75
15
A
THR
39
-150.07
66.94
16
A
HIS
13
62.79
97.49
16
A
LEU
16
-151.44
-53.88
16
A
GLN
35
-141.09
29.41
16
A
THR
39
-108.39
41.77
17
A
ILE
27
-137.18
-51.41
18
A
LEU
8
-100.74
-86.75
18
A
HIS
13
62.60
83.33
19
A
LEU
8
-96.70
35.18
19
A
LEU
28
-97.71
47.48
19
A
GLN
35
-149.24
24.53
19
A
THR
39
-156.22
39.63
20
A
ASP
3
-121.25
-59.57
20
A
HIS
13
-168.82
64.21
20
A
PRO
30
-70.30
-83.34
20
A
MET
32
-175.24
-55.02
20
A
GLN
35
-161.39
33.65
21
A
ALA
4
-173.18
-52.54
21
A
ALA
11
-118.44
-72.42
21
A
ILE
12
56.71
18.86
22
A
ASP
3
-167.53
-61.58
22
A
ILE
38
-102.12
57.02
22
A
THR
39
-163.78
59.93
23
A
ARG
2
-115.51
-166.99
23
A
ALA
4
-178.35
-47.77
23
A
ILE
27
-128.89
-50.77
24
A
ASP
3
-131.14
-58.94
24
A
ILE
12
55.47
-178.72
24
A
GLN
35
-144.53
25.22
25
A
ALA
36
-101.20
79.31
25
A
ILE
38
-95.67
34.68
25
A
THR
39
-115.13
50.72
26
A
ALA
4
-174.66
-51.79
26
A
ALA
11
-98.25
42.35
26
A
ILE
27
-139.14
-51.98
27
A
ALA
4
-173.54
-55.23
27
A
ILE
12
-63.65
-173.81
27
A
PRO
14
-67.54
-160.90
27
A
LEU
16
-144.10
-53.87
27
A
LEU
28
-157.18
76.20
27
A
GLN
35
-150.45
26.00
27
A
THR
39
-144.40
-54.56
28
A
ALA
11
-101.29
46.83
28
A
HIS
13
67.21
106.86
28
A
ILE
27
-109.25
48.40
28
A
GLN
35
-146.49
24.88
28
A
ILE
38
-114.87
50.40
28
A
THR
39
-154.55
49.82
29
A
ILE
27
-126.93
-52.71
29
A
LEU
28
57.83
71.58
29
A
GLN
35
-141.89
31.14
29
A
THR
39
-145.96
-72.51
30
A
ALA
11
-94.16
35.21
30
A
LEU
16
-167.75
-51.09
30
A
PRO
30
-93.36
53.56
30
A
THR
39
-107.97
48.35
31
A
ALA
36
-107.26
57.76
32
A
CYS
10
-95.66
37.23
32
A
ALA
11
-157.74
38.24
32
A
GLN
35
-152.53
29.26
33
A
ALA
4
-175.13
-52.55
33
A
ILE
27
-128.32
-53.35
34
A
ILE
12
58.49
91.46
34
A
PRO
14
-65.02
-177.34
34
A
LEU
16
-152.10
-53.89
34
A
THR
39
-152.23
67.24
35
A
ALA
11
-105.72
50.58
35
A
HIS
13
-151.08
66.23
35
A
LEU
28
-106.72
-74.61
35
A
THR
39
-110.07
51.50
36
A
LEU
16
-159.67
-51.12
36
A
LEU
28
-87.20
30.94
37
A
ASP
3
-161.88
-64.99
37
A
ALA
36
-107.25
76.31
38
A
ALA
11
-113.94
-70.53
38
A
ILE
12
40.29
29.63
38
A
HIS
13
60.60
92.18
38
A
THR
39
-108.74
42.76
39
A
LEU
16
-174.65
-51.78
39
A
ALA
36
-103.65
76.11
40
A
HIS
13
-150.33
59.30
40
A
GLU
15
59.66
13.96
40
A
LEU
16
-143.04
-59.76
40
A
ILE
27
-120.97
-69.20
40
A
THR
39
-112.94
54.28
41
A
ARG
2
-102.61
-165.98
41
A
ALA
4
-170.72
-54.03
41
A
PRO
30
-90.14
38.19
Protease NS2-3
closest to the average, model 1
Solution structure of NS2 [60-99]
1
N
N
A
ALA
4
A
ALA
4
HELX_P
A
ILE
12
A
ILE
12
1
1
9
A
HIS
13
A
HIS
13
HELX_P
A
ILE
27
A
ILE
27
1
2
15
A
GLY
29
A
GLY
29
HELX_P
A
LEU
34
A
LEU
34
1
3
6
VIRAL PROTEIN
Hepatitis C Virus, NS2 domain, Viral protein, membrane protein
POLG_HCVCO
UNP
1
869
Q9WMX2
GRDAVILLTCAIHPELIFTITKILLAILGPLMVLQAGITK
869
908
2KWZ
1
40
Q9WMX2
A
1
1
40